RETRACTED: NRH:Quinone oxidoreductase 2 and NAD(P)H:quinone oxidoreductase 1 protect tumor suppressor p53 against 20S proteasomal degradation leading to stabilization and activation of p53 (Retracted article. See vol. 75, pg. 615, 2015)

被引:89
|
作者
Gong, Xing [1 ]
Kole, Labanyamoy [1 ]
Iskander, Karim [1 ]
Jaiswal, Anil K. [1 ]
机构
[1] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA
关键词
D O I
10.1158/0008-5472.CAN-07-0323
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor suppressor p53 is either lost or mutated in several types of cancer. MDM2 interaction with p53 results in ubiquitination and 26S proteasomal degradation of p53 Chronic DNA damage leads to inactivation of MDM2 stabilization of p53, and apoptotic cell death. Here, we presen; a novel MDM2/ubiquitination-independent mechanism of stabilization and transient activation of p53. The present studies show that 20S proteasomes degrade p53. The 20S degradation of p53 was observed in ubiquitin-efficient and -deficient cells, indicating that this pathway of degradation did not require ubiquitination of p53. The cytosolic quinone oxidoreductases [NRH:quinone oxidoreductase 2 (NQ02) and NAD(P)H:quinone oxidoreductase I (NQ01)] interacted with p53 and protected p53 against 20S proteasomal degradation. Further studies revealed that acute exposure to radiation or chemical leads to induction of NQ01 and NQ02 that stabilizes and transiently activates p53 and downstream genes. These results suggest that stress-induced NQ01 and NQ02 transiently stabilize p53, which leads to protection against adverse effects of stressors.
引用
收藏
页码:5380 / 5388
页数:9
相关论文
共 41 条
  • [1] NRH:Quinone Oxidoreductase 2 and NAD(P)H:Quinone Oxidoreductase 1 Protect Tumor Suppressor p53 against 20S Proteasomal Degradation Leading to Stabilization and Activation of p53 (Retraction of vol 67, pg 5380, 2007)
    Iskander, Karim
    Jaiswal, Anil K.
    CANCER RESEARCH, 2015, 75 (03) : 615 - 615
  • [2] RETRACTED: Disruption of NAD(P)H:quinone oxidoreductase 1 gene in mice leads to 20S proteasomal degradation of p63 resulting in thinning of epithelium and chemical-induced skin cancer (Retracted article. See vol. 36, pg. 2919, 2017)
    Patrick, B. A.
    Gong, X.
    Jaiswal, A. K.
    ONCOGENE, 2011, 30 (09) : 1098 - 1107
  • [3] RETRACTED: Disruption of the NAD(P)H:quinone oxidoreductase 1 (NQO1) gene in mice causes myelogenous hyperplasia (Retracted article. See vol. 78, pg. 6526, 2018)
    Long, DJ
    Gaikwad, A
    Multani, A
    Pathak, S
    Montgomery, CA
    Gonzalez, FJ
    Jaiswal, AK
    CANCER RESEARCH, 2002, 62 (11) : 3030 - 3036
  • [4] NAD(P)H:quinone oxidoreductase 1 controls p63 via stabilization of C/EBP\#945; against 20S proteasomal degradation
    Patrick, Brad
    Gong, Xing
    Jaiswal, Anil
    CANCER RESEARCH, 2009, 69
  • [5] NAD(P)H:quinone oxidoreductase 1 stabilizes C/EBPα from 20S proteasomal degradation leading to protection against myeloproliferative disease
    Xu, Junkang
    Jaiswal, Anil
    CANCER RESEARCH, 2012, 72
  • [6] RETRACTED: Efficient Reactivation of p53 in Cancer Cells by a Dual MdmX/Mdm2 Inhibitor (Retracted article. See vol. 137, pg. 14546, 2015)
    Qin, Lingyun
    Yang, Fei
    Zhou, Cindy
    Chen, Yao
    Zhang, Huashan
    Su, Zhengding
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2014, 136 (52) : 18023 - 18033
  • [7] Interaction of human NAD(P)H:Quinone oxidoreductase 1 (NQO1) with the tumor suppressor protein p53 in cells and cell-free systems
    Anwar, A
    Dehn, D
    Siegel, D
    Kepa, JK
    Tang, LJ
    Pietenpol, JA
    Ross, D
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (12) : 10368 - 10373
  • [8] RETRACTED: NAD(P) H:quinone Oxidoreductase 1 (NQO1) Competes with 20S Proteasome for Binding with C/EBPα Leading to Its Stabilization and Protection against Radiation-induced Myeloproliferative Disease (Retracted Article)
    Xu, Junkang
    Jaiswal, Anil K.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (50) : 41608 - 41618
  • [9] RETRACTED: Transactivation of the EGR1 gene contributes to mutant p53 gain of function (Retracted article. See vol. 79, pg. 2085, 2019)
    Weisz, L
    Zalcenstein, A
    Stambolsky, P
    Cohen, Y
    Goldfinger, N
    Oren, M
    Rotter, V
    CANCER RESEARCH, 2004, 64 (22) : 8318 - 8327
  • [10] RETRACTED: UHRF2, another E3 ubiquitin ligase for p53 (Retracted article. See vol. 440, pg. 803, 2013)
    Bai, Lu
    Wang, Xiaohui
    Jin, Fangmin
    Yang, Yan
    Qian, Guanhua
    Duan, Changzhu
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 425 (04) : 908 - 911